Back to search results

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Abroad (travel likely)Recruiting

Conditions

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Cutaneous Squamous Cell Carcinoma of the Head and Neck · Head and Neck Carcinoma of Unknown Primary · Head and Neck Squamous Cell Carcinoma · Hypopharyngeal Squamous Cell Carcinoma · Laryngeal Squamous Cell Carcinoma · Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck · Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Hypopharyngeal Squamous Cell Carcinoma · Metastatic Laryngeal Squamous Cell Carcinoma · Metastatic Nasopharyngeal Squamous Cell Carcinoma · Metastatic Oral Cavity Squamous Cell Carcinoma · Metastatic Oropharyngeal Squamous Cell Carcinoma · Metastatic Paranasal Sinus Squamous Cell Carcinoma · Nasopharyngeal Squamous Cell Carcinoma · Oral Cavity Squamous Cell Carcinoma · Oropharyngeal Squamous Cell Carcinoma · Paranasal Sinus Squamous Cell Carcinoma · Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck · Recurrent Head and Neck Squamous Cell Carcinoma · Recurrent Hypopharyngeal Squamous Cell Carcinoma · Recurrent Laryngeal Squamous Cell Carcinoma · Recurrent Nasopharyngeal Squamous Cell Carcinoma · Recurrent Oral Cavity Squamous Cell Carcinoma · Recurrent Oropharyngeal Squamous Cell Carcinoma · Recurrent Paranasal Sinus Squamous Cell Carcinoma · Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 · Stage IV Hypopharyngeal Carcinoma AJCC v8 · Stage IV Laryngeal Cancer AJCC v8 · Stage IV Lip and Oral Cavity Cancer AJCC v8 · Stage IV Nasopharyngeal Carcinoma AJCC v8 · Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IV Sinonasal Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Emory Midtown University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Nicole C. Schmitt) · nicole.cherie.schmitt@emory.edu · 404-778-1900
    Contact: Principal Investigator (Nicole C. Schmitt)
Study leads

  • Nicole C Schmitt, MD, FACS

    Principal Investigator

    Emory University Hospital/Winship Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)